• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Defining Value for the Treatment of Brain Metastases in Metastatic HER2-Positive Breast Cancer

home / insights / defining-value-for-the-treatment-of-brain-metastases-in-metastatic-her2-positive-breast-cancer

Examining current treatment options for brain metastases in metastatic HER2+ breast cancer and assessing the clinical and economic burden.

© 2023 MJH Life Sciences
All rights reserved.